Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1367519 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages |
Abstract
The design and synthesis of a new series of c-Jun N-terminal kinase-3 (JNK3) inhibitors with selectivity against JNK1 are reported. The novel series of substituted 2′-anilino-4,4′-bipyridines were designed based on a combination of hits from high throughput screening and X-ray crystal structure information of compounds crystallized into the JNK3 ATP binding active site.
Graphical abstractThe design and synthesis of new c-Jun N-terminal kinase-3 inhibitors (JNK3) with selectivity against JNK1 and p38α are reported. Compound 18 displayed the best selectivity against JNK1 within the series.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Britt-Marie Swahn, Yafeng Xue, Erwan Arzel, Elisabet Kallin, Angelika Magnus, Niklas Plobeck, Jenny Viklund,